Skuamokolumnar bileşkede inflamasyon ve intestinal metaplazi: Helicobecter pylori infeksiyonunun rolü

Giriş ve amaç: Batı ülkelerinde Helicobacter pylori (Hp) prevalansmın azalması ile birlikte, özofagus ve kardiya adenokarsinomalarının insidansında artış olduğu bildirilmektedir. Türkiye'de yetişkin popülasyonda Hp pozitifliği halen %75'in üzerindedir. Klasik Barrett özofagusu bulunmayan hastalarda, gastroözofageal bileşkedeki adenokarsinomalann, gastroskopiye giren hastaların % 9-36'sında saptanan, skuamokolumnar bileşkedeki intestinal metaplazi (İM) odaklarından köken aldıkları görülmektedir. ÎM'nin, kronik inflamasyonun bir sonucu olduğu var sayılmaktadır. Skuamokolumnar bileşke (SKB)'deki ÎM'de, bu bölgedeki inflamasyon gibi, Hp veya gastroözofageal reflü hastalığı ile ilişkilidir. Bu çalışmanın amacı, SKB'deki inflamasyon ve İM'nin, Hp pozitifliği yüksek olan bir popülasyonda araştırılması; sözkonusu bakteri ile mul-tipl endoskopik biyopsi örnekleri alınarak olası korelasyonlarını belirlemektir. Gereç ve yöntem: Bu çalışmada, özofagogastroduodenoskopi için başvuran 38 hastada (30 erkek, 8 kadın) gastrik fundus, korpus, antrum, postbulber bölge, SKB ve özofagustan endoskopik biyopsiler alındı. Biyopsi örnekleri tek bir patolog tarafından inflamasyon, aktivite, atrofi varlığı, gastrik ve kardiyak İM açısından değerlendirildi. Bulgular: Sonuçta çalışma grubunda 36 gastrit hastasının 29'unda kronik Hp gastriti; 38 hastanın 28'inde (% 73.5) histolojik özofajit; 38 hastanın 37'sinde (%97) SKB'de inflamasyon, 5'inde (%13) İM (4'ü komplet, 1'i in-komplet) saptandı. Fundus, korpus ve antrumdaki inflamasyon ve aktivite arasında anlamlı korelasyon saptandı (p

Inflamation and intestinal metaplasia in the squamocolumnar junction: The role of Helicobacter pylori infection

Background/aim: It is reported that the incidence of adenocarcinoma of the cardia and esophagus has increased in western countries simultaneously with a decrease in Helicobacter pylori (Hp) prevalence. In Turkey, Hp positivity is still above 75% in the adult population. In patients without classic Barrett's esophagus, adenocarcinomas of the gastroesopha-geal junction appear to arise from foci of intestinal metaplasia (IM) at the squamocolumnar junction (SCJ), which occur in 9-36% of patients un¬dergoing gastroscopy. IM is assumed to be a consequence of chronic inflammation. Like inflammation at the SCJ, IM at the cardia has also been associated either with Hp gastritis or with gastroesophageal reflux disease. The aim of this study was detection of IM and inflammation at SCJ in a population with high Hp positivity, by multiple biopsy speci¬mens, and definition of probable correlations. Materials and methods: In this study, endoscopic biopsy specimens were taken from 38 patients» (30 male, 8 female) who presented for esophagogastroduodenoscopy (from gastric fundus, corpus, antrum, second portion of duodenum, SCJ, esophagus). Biopsy specimens were examined by one pathologist for inflammation, activity, and presence of atrophy and gastric-cardiac IM. Results: Chronic Hp gastritis was detected in 29 of 36 patients with gastritis; histologic esophagitis in 28 of 38 patients (73.5%); inflammation at SCJ in 37 of 38 patients (97%); and IM at SCJ in 5 of 38 patients (13%)(4 complete, 1 incomplete). A significant correlation was detected between inflammation and activity in fundus, corpus and antrum (p<0.05). Biopsy specimens taken from the columnar side of the SCJ were oxyntic in 24, cardiac in 12, and squamous in 1. Comparison of the patients detected to have oxyntic and cardiac mucosa revealed that the mean age of the patients in the first group was significantly lower than that of the second group (p<0.01). Conclusion: We have shown, in a population with high Hp prevalence, a correlation between inflammation at the gastric cardia and IM with chronic gastritis caused by the aforementioned bacterium; but put forward complete type IM, which is infrequently associated with adenocarcinoma, has been seen.

___

  • 1.Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.Cancer 1998; 83: 2049-53.
  • 2.Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109:1541-6.
  • 3.Clark GW, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129: 609-14.
  • 4.Fenoglio-Preiser CM, Nojfsinger AE, Stemmerman GM, et al. Gastrointestinal pathology. An atlas and text, 2nd edition, Philadelphia: Raven Lippincott, 1999:133.
  • 5.Chandrasoma PT, Lokuhetty DM, Demeester TR, et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 2000; 24:344-51.
  • 6.Madri JA. Inflammation and healing. In: Kissane JM, ed. Anderson's pathology. Volume 1. 9th ed. St. Louis, MO: Mosby, 1990: 67-110.
  • 7.Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis", and Barrett's esophagus and sequela of therapy. Am J Surg Pathol 1996 (20 suppl 1); S31-50. Review.
  • 8.Clark GWB, Ireland AP, Chandrasoma P, et al. Inflammation and metaplasia in the transitional epithelium of the gastrooesophageal junction-A new marker for gastroesophageal reflux disease. Gastroenterology 106 (4): A63-A63 Suppl. S Apr 1994.
  • 9.Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994; 25: 915-9.
  • 10.Goldblum JR, Vicari JJ, Faik GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998; 114: 633-9.
  • 11.Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226: 522-30; discussion 530-32.
  • 12.Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
  • 13.Macdonald CE, Wicks AC, Playford RJ. Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut 1997; 41: 303-7.
  • 14.Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344:1533-6.
  • 15.Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999; 94: 86-91.
  • 16.Conio M, Cameron AJ, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut. 2001; 48: 304-9.
  • 17.Johnston MH, Hammond AS, Laskin W, et al. The prevalance and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenteroi 1996; 91:1507-11.
  • 18.Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997; 40: 710-5.
  • 19.Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999; 117: 218-28. Review.
  • 20.Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997; 41: 585-9.
  • 21.Ormsby AH, Kilgore SP, Goldblum JR, et al. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: Implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000; 13:614-20.
  • 22.Blaser MJ. Hypothesis: The changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999; 179:1523-30.
  • 23.Özden A ve ark. Helicobacter pylori infeksiyonunun ülkemizdeki seroepidemiyolojisi. Turk J Gastroenterol 1992; 3(4): 664-68.0
  • 24.Özden A ve ark. Dispeptik yakınmalarla başvuran hastalarda H. pylori infeksiyonu ile dispepsi subgruplan ve dispeptik semptomlar arasındaki ilişki. Turk J Gastroenterol 2000; 11, Supplement 1.
  • 25.Oksanen A, Sipponen P, Karttunen R, et al. Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection. Gut 2003; 52:194-8.
  • 26.Chandrasoma PT, Der R, Ma Y, et al. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000; 24:402-9.
  • 27.Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact orfistion? Am J Gastroenterol 2000; 95: 921-4.
  • 28.Bowrey DJ, Clark GW, Williams GT. Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999; 45: 798-803.
  • 29.Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study ofH. pylori density and distribution. Gastrointest Endosc 1994; 40: 342-5.
  • 30.Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centers. Gut 1985; 26:1319-26.
  • 31.Voutilainen M, Farkkila M, Juhola M, et al. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut 1999; 45: 644-8.
  • 32.Aste H, Bonelli L, Ferraris R, et al. Gastroesophageal reflux disease: relationship between clinical and histological features. GOS-PE. Gruppo Operativo per lo. Studio delle Precancerosi dell'Esofago. Dig Dis Sci 1999; 44: 2412-8.
  • 33.Eloubeidi MA, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1999; 94: 937-43.
  • 34.Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998; 43:17-21.
Akademik Gastroenteroloji Dergisi-Cover
  • ISSN: 1303-6629
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2002
  • Yayıncı: Jülide Gülay Özler
Sayıdaki Diğer Makaleler

Hipertrigliseridemi nedenli akut pankreatit tedavisinde heparin ve insülin rejimi uygulanan bir olgu

Şerif YILMAZ, Mehmet DURSUN, Fikri CANORUÇ, ALPASLAN KEMAL TUZCU, Hatice AKAY, Ramazan DANIŞ, Ergun PARMAKSIZ

Akut pankreatitin gidişi üzerine kontrastlı tomografi etkili midir?

Refik MAS

Kolesistektomi sonrası oluşan Mirizzi sendromu olgusu

Murat ASLAN, Yüksel ATEŞ, Mustafa GÜLŞEN, Sait BAĞCI, Güldem KİLCİLER, Zülfikar POLAT, Ahmet TÜZÜN, Necmettin KARAEREN, Kemal DAĞALP

Skuamokolumnar bileşkede inflamasyon ve intestinal metaplazi: Helicobecter pylori infeksiyonunun rolü

Murat CİĞERİM, Ahmet TÜZÜN, Mustafa GÜLŞEN, Yüksel ATEŞ, Ömer GÜNHAN, Zülfikar POLAT, Murat ASLAN, Necmettin KARAEREN, Kemal DAĞALP

Deneysel akut pankreatit modelinde kontrast madde etkisi

Mahmut ÖKSÜZLER, Tarkan ÜNEK, Çağnur ULUKUŞ, Murat ZEYTUNLU, Özgül SAĞOL, Yiğit GÖKTAY, Canan ÇOKER, Ahmet ÇOKER

Tanısal amaçlı endoskopik ultrasonografi yapılan hastalarda bilinçli sedasyon: Midazolam ile plaseboyu karşılaştıran randomize, çift kör, kontrollü çalışma

Dilek OĞUZ, Aydın Şeref KÖKSAL, Bahattin ÇİÇEK, Erkan PARLAK, Burhan ŞAHİN

İleri referans merkezinde yatırılan irritabl barsak sendromlularda batın ve anorektal cerrahi sıklığı

ELMAS KASAP, Serhat BOR, Tankut İLTER

Klaritromisin dirençli Helicobacter pylori'nin saptanmasında E-test ve Agar dilüsyon metodlarının karşılaştırılması

Peren H. BAĞLAN, Gülendam BOZDAYI, Muhip ÖZKAN, Ali ÖZDEN

Portal ven trombozunun nadir bir sebebi: Paroksismal nokturnal hemoglobinüri

Gönenç KOCABAY, Çetin KARACA, Kadir DEMİR, Engin TÜRKMEN, BETÜL TİRYAKİ BAŞTUĞ, Uğur ÇEVİKBAŞ, Fatih BEŞIŞIK, Yılmaz ÇAKALOĞLU, Atilla ÖKTEN

Ailesel Akdeniz Ateşi olan hastalarda lenfosit alt grupları ve serum adenozin deaminaz düzeyleri

Yüksel ATEŞ, Hakkı ERGÜN, Ahmet TÜZÜN, Sait BAĞCI, İsmail KURT, ALİ İNAL, Zülfikar POLAT, Necmettin KARAEREN, Kemal DAĞALP